Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma

Masafumi Seki, Riki Nishimura, Kenichi Yoshida, Teppei Shimamura, Yuichi Shiraishi, Yusuke Sato, Motohiro Kato, Kenichi Chiba, Hiroko Tanaka, Noriko Hoshino, Genta Nagae, Yusuke Shiozawa, Yusuke Okuno, Hajime Hosoi, Yukichi Tanaka, Hajime Okita, Mitsuru Miyachi, Ryota Sozaki, Tomoaki Taguchi, Katsuyoshi KohRyoji Hanada, Keisuke Kato, Yuko Nomura, Masaharu Akiyama, Akira Oka, Takashi Igarashi, Satoru Miyano, Hiroyuki Aburatani, Yasuhide Hayashi, Seishi Ogawa, Junko Takita

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in childhood. Here we studied 60 RMSs using whole-exome/-transcriptome sequencing, copy number (CN) and DNA methylome analyses to unravel the genetic/epigenetic basis of RMS. On the basis of methylation patterns, RMS is clustered into four distinct subtypes, which exhibits remarkable correlation with mutation/CN profiles, histological phenotypes and clinical behaviours. A1 and A2 subtypes, especially A1, largely correspond to alveolar histology with frequent PAX3/7 fusions and alterations in cell cycle regulators. In contrast, mostly showing embryonal histology, both E1 and E2 subtypes are characterized by high frequency of CN alterations and/or allelic imbalances, FGFR4/RAS/AKT pathway mutations and PTEN mutations/methylation and in E2, also by p53 inactivation. Despite the better prognosis of embryonal RMS, patients in the E2 are likely to have a poor prognosis. Our results highlight the close relationships of the methylation status and gene mutations with the biological behaviour in RMS.

Original languageEnglish
Article number7557
JournalNature communications
Volume6
DOIs
Publication statusPublished - Jul 3 2015

Fingerprint

Methylation
Rhabdomyosarcoma
mutations
subgroups
Epigenomics
methylation
Histology
Mutation
histology
prognosis
Allelic Imbalance
Embryonal Rhabdomyosarcoma
Exome
phenotype
sequencing
regulators
Fusion reactions
Genes
Transcriptome
Cells

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Seki, M., Nishimura, R., Yoshida, K., Shimamura, T., Shiraishi, Y., Sato, Y., ... Takita, J. (2015). Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma. Nature communications, 6, [7557]. https://doi.org/10.1038/ncomms8557

Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma. / Seki, Masafumi; Nishimura, Riki; Yoshida, Kenichi; Shimamura, Teppei; Shiraishi, Yuichi; Sato, Yusuke; Kato, Motohiro; Chiba, Kenichi; Tanaka, Hiroko; Hoshino, Noriko; Nagae, Genta; Shiozawa, Yusuke; Okuno, Yusuke; Hosoi, Hajime; Tanaka, Yukichi; Okita, Hajime; Miyachi, Mitsuru; Sozaki, Ryota; Taguchi, Tomoaki; Koh, Katsuyoshi; Hanada, Ryoji; Kato, Keisuke; Nomura, Yuko; Akiyama, Masaharu; Oka, Akira; Igarashi, Takashi; Miyano, Satoru; Aburatani, Hiroyuki; Hayashi, Yasuhide; Ogawa, Seishi; Takita, Junko.

In: Nature communications, Vol. 6, 7557, 03.07.2015.

Research output: Contribution to journalArticle

Seki, M, Nishimura, R, Yoshida, K, Shimamura, T, Shiraishi, Y, Sato, Y, Kato, M, Chiba, K, Tanaka, H, Hoshino, N, Nagae, G, Shiozawa, Y, Okuno, Y, Hosoi, H, Tanaka, Y, Okita, H, Miyachi, M, Sozaki, R, Taguchi, T, Koh, K, Hanada, R, Kato, K, Nomura, Y, Akiyama, M, Oka, A, Igarashi, T, Miyano, S, Aburatani, H, Hayashi, Y, Ogawa, S & Takita, J 2015, 'Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma', Nature communications, vol. 6, 7557. https://doi.org/10.1038/ncomms8557
Seki, Masafumi ; Nishimura, Riki ; Yoshida, Kenichi ; Shimamura, Teppei ; Shiraishi, Yuichi ; Sato, Yusuke ; Kato, Motohiro ; Chiba, Kenichi ; Tanaka, Hiroko ; Hoshino, Noriko ; Nagae, Genta ; Shiozawa, Yusuke ; Okuno, Yusuke ; Hosoi, Hajime ; Tanaka, Yukichi ; Okita, Hajime ; Miyachi, Mitsuru ; Sozaki, Ryota ; Taguchi, Tomoaki ; Koh, Katsuyoshi ; Hanada, Ryoji ; Kato, Keisuke ; Nomura, Yuko ; Akiyama, Masaharu ; Oka, Akira ; Igarashi, Takashi ; Miyano, Satoru ; Aburatani, Hiroyuki ; Hayashi, Yasuhide ; Ogawa, Seishi ; Takita, Junko. / Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma. In: Nature communications. 2015 ; Vol. 6.
@article{8b96e720efbc4bacb293a4d1025a16df,
title = "Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma",
abstract = "Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in childhood. Here we studied 60 RMSs using whole-exome/-transcriptome sequencing, copy number (CN) and DNA methylome analyses to unravel the genetic/epigenetic basis of RMS. On the basis of methylation patterns, RMS is clustered into four distinct subtypes, which exhibits remarkable correlation with mutation/CN profiles, histological phenotypes and clinical behaviours. A1 and A2 subtypes, especially A1, largely correspond to alveolar histology with frequent PAX3/7 fusions and alterations in cell cycle regulators. In contrast, mostly showing embryonal histology, both E1 and E2 subtypes are characterized by high frequency of CN alterations and/or allelic imbalances, FGFR4/RAS/AKT pathway mutations and PTEN mutations/methylation and in E2, also by p53 inactivation. Despite the better prognosis of embryonal RMS, patients in the E2 are likely to have a poor prognosis. Our results highlight the close relationships of the methylation status and gene mutations with the biological behaviour in RMS.",
author = "Masafumi Seki and Riki Nishimura and Kenichi Yoshida and Teppei Shimamura and Yuichi Shiraishi and Yusuke Sato and Motohiro Kato and Kenichi Chiba and Hiroko Tanaka and Noriko Hoshino and Genta Nagae and Yusuke Shiozawa and Yusuke Okuno and Hajime Hosoi and Yukichi Tanaka and Hajime Okita and Mitsuru Miyachi and Ryota Sozaki and Tomoaki Taguchi and Katsuyoshi Koh and Ryoji Hanada and Keisuke Kato and Yuko Nomura and Masaharu Akiyama and Akira Oka and Takashi Igarashi and Satoru Miyano and Hiroyuki Aburatani and Yasuhide Hayashi and Seishi Ogawa and Junko Takita",
year = "2015",
month = "7",
day = "3",
doi = "10.1038/ncomms8557",
language = "English",
volume = "6",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma

AU - Seki, Masafumi

AU - Nishimura, Riki

AU - Yoshida, Kenichi

AU - Shimamura, Teppei

AU - Shiraishi, Yuichi

AU - Sato, Yusuke

AU - Kato, Motohiro

AU - Chiba, Kenichi

AU - Tanaka, Hiroko

AU - Hoshino, Noriko

AU - Nagae, Genta

AU - Shiozawa, Yusuke

AU - Okuno, Yusuke

AU - Hosoi, Hajime

AU - Tanaka, Yukichi

AU - Okita, Hajime

AU - Miyachi, Mitsuru

AU - Sozaki, Ryota

AU - Taguchi, Tomoaki

AU - Koh, Katsuyoshi

AU - Hanada, Ryoji

AU - Kato, Keisuke

AU - Nomura, Yuko

AU - Akiyama, Masaharu

AU - Oka, Akira

AU - Igarashi, Takashi

AU - Miyano, Satoru

AU - Aburatani, Hiroyuki

AU - Hayashi, Yasuhide

AU - Ogawa, Seishi

AU - Takita, Junko

PY - 2015/7/3

Y1 - 2015/7/3

N2 - Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in childhood. Here we studied 60 RMSs using whole-exome/-transcriptome sequencing, copy number (CN) and DNA methylome analyses to unravel the genetic/epigenetic basis of RMS. On the basis of methylation patterns, RMS is clustered into four distinct subtypes, which exhibits remarkable correlation with mutation/CN profiles, histological phenotypes and clinical behaviours. A1 and A2 subtypes, especially A1, largely correspond to alveolar histology with frequent PAX3/7 fusions and alterations in cell cycle regulators. In contrast, mostly showing embryonal histology, both E1 and E2 subtypes are characterized by high frequency of CN alterations and/or allelic imbalances, FGFR4/RAS/AKT pathway mutations and PTEN mutations/methylation and in E2, also by p53 inactivation. Despite the better prognosis of embryonal RMS, patients in the E2 are likely to have a poor prognosis. Our results highlight the close relationships of the methylation status and gene mutations with the biological behaviour in RMS.

AB - Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in childhood. Here we studied 60 RMSs using whole-exome/-transcriptome sequencing, copy number (CN) and DNA methylome analyses to unravel the genetic/epigenetic basis of RMS. On the basis of methylation patterns, RMS is clustered into four distinct subtypes, which exhibits remarkable correlation with mutation/CN profiles, histological phenotypes and clinical behaviours. A1 and A2 subtypes, especially A1, largely correspond to alveolar histology with frequent PAX3/7 fusions and alterations in cell cycle regulators. In contrast, mostly showing embryonal histology, both E1 and E2 subtypes are characterized by high frequency of CN alterations and/or allelic imbalances, FGFR4/RAS/AKT pathway mutations and PTEN mutations/methylation and in E2, also by p53 inactivation. Despite the better prognosis of embryonal RMS, patients in the E2 are likely to have a poor prognosis. Our results highlight the close relationships of the methylation status and gene mutations with the biological behaviour in RMS.

UR - http://www.scopus.com/inward/record.url?scp=84936802728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936802728&partnerID=8YFLogxK

U2 - 10.1038/ncomms8557

DO - 10.1038/ncomms8557

M3 - Article

C2 - 26138366

AN - SCOPUS:84936802728

VL - 6

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 7557

ER -